These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 8706304)

  • 1. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
    Crofton PM; Stirling HF; Schönau E; Kelnar CJ
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R; Gunczler P; Esaa S; Weisinger JR
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone turnover.
    Crofton PM; Stirling HF; Schönau E; Ahmed SF; Wallace WH; Wade JC; Magowan R; Shrivastava A; Lyon AJ; McIntosh N; Kelnar CJ
    Horm Res; 1996; 45 Suppl 1():55-8. PubMed ID: 8805033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term changes in bone formation markers following growth hormone (GH) treatment in short prepubertal children with a broad range of GH secretion.
    Andersson B; Swolin-Eide D; Magnusson P; Albertsson-Wikland K
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):91-9. PubMed ID: 24818653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.
    Tobiume H; Kanzaki S; Hida S; Ono T; Moriwake T; Yamauchi S; Tanaka H; Seino Y
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
    van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A; Conti A; Monzani M
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone metabolism markers and bone mass in healthy pubertal boys and girls.
    van Coeverden SC; Netelenbos JC; de Ridder CM; Roos JC; Popp-Snijders C; Delemarre-van de Waal HA
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):107-16. PubMed ID: 12100078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of bone turnover in children with GH deficiency treated with GH until final height.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Cupelli D; Saggese G
    Eur J Endocrinol; 2000 Jun; 142(6):549-56. PubMed ID: 10822216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia.
    Crofton PM; Ahmed SF; Wade JC; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
    Pediatr Res; 2000 Oct; 48(4):490-6. PubMed ID: 11004240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen formation and degradation increase during growth hormone therapy in children.
    Vihervuori E; Turpeinen M; Siimes MA; Koistinen H; Sorva R
    Bone; 1997 Feb; 20(2):133-8. PubMed ID: 9028537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH.
    Kamp GA; Zwinderman AH; Van Doorn J; Hackeng W; Frölich M; Schönau E; Wit JM
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):315-25. PubMed ID: 12201823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
    Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
    Beshyah SA; Kyd P; Thomas E; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malnutrition, zinc supplementation and catch-up growth: changes in insulin-like growth factor I, its binding proteins, bone formation and collagen turnover.
    Doherty CP; Crofton PM; Sarkar MA; Shakur MS; Wade JC; Kelnar CJ; Elmlinger MW; Ranke MB; Cutting WA
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):391-9. PubMed ID: 12201833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone alkaline phosphatase and height velocity in short normal children undergoing growth-promoting treatments: longitudinal study.
    Crofton PM; Stirling HF; Kelnar CJ
    Clin Chem; 1995 May; 41(5):672-8. PubMed ID: 7729044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.